ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 706

Undifferentiated Spondylarthritis May More Frequent in Japanese

Hitoshi Goto1, Noriyuki Hayashi1, Shinsuke Yamada2 and Masaaki Inaba3, 1Rheumatology, Osaka City University Graduate School of Medicine, Osaka, Japan, 2Rheumatology, Osaka City University Graduate School of Midicine, Osaka, Japan, 3Osaka City University Graduate School of Medicine, Osaka, Japan

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Back pain, enthesis and spondylarthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 8, 2015

Title: Spondylarthropathies and Psoriatic Arthritis - Clinical Aspects and Treatment Poster I: Clinical Aspects and Assessments

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:  Because of low frequency of HLA-B27 (lower than 1%), the prevalence of the spondarthritis (SpA) is thought to be much lower than rheumatoid arthritis (RA) in Japanese. Therefore an evaluation of the inflammatory back pain and enthesitis is not routinely performed, and early diagnosis of the spondarthritis (SpA) is not substantially performed. We examined the presence of clinical findings to suggest SpA in each of the positive cases of the anti-cyclic citrullinated peptide antibody(ACPA) and the negative cases of ACPA in Japanese.

Methods: We randomly selected 300 cases from the patients who had musculoskeletal symptoms as chief complaint in outpatient clinic of Rheumatology, Osaka City University Hospital.We retrospectively examined frequency of clinical findings of SpA including enthesitis, dactylitis, the arthritis of axis joints and the inflammatory back pain according to clinical records in cases of ACPA positive, and ACPA negative.

Results: Among 300 cases, 95 cases showed positive of ACPA and 205 cases showed negative. In the ACPA positive cases, only two cases showed more than one enthesitis, but 88 cases showed either enthesitis (80 cases) or ductilitis (10 cases), the arthritis of axis joints (62 cases), inflammatory lumbago (2 cases) in the ACPA negative cases. The cases with findings to suggest potential of SpA are more frequently in ACPA-negative cases in Japanese. However, the patients themselves actually rarely reported these symptoms, therefore findings suggesting SpA were possibly missed unless we took physical examination adequately.

Conclusion: The Japanese SpA patients may have relatively mild symptoms and may be diagnosed seronegative RA rather than undifferentiated SpA. It is necessary to take physical examination appropriately in ACPA-negative Japanese patients even if they meet classification criteria of RA to prevent passing over SpA, moreover it is necessary to find genetic marker in Japanese such as HLA-B27 in Caucasian.


Disclosure: H. Goto, None; N. Hayashi, None; S. Yamada, None; M. Inaba, None.

To cite this abstract in AMA style:

Goto H, Hayashi N, Yamada S, Inaba M. Undifferentiated Spondylarthritis May More Frequent in Japanese [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/undifferentiated-spondylarthritis-may-more-frequent-in-japanese/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/undifferentiated-spondylarthritis-may-more-frequent-in-japanese/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology